期刊文献+

γ-干扰素加强TRAIL抑制人大肠癌细胞株作用的研究 被引量:2

IFN-γ reinforces the inhibitory effect of tumor necrosis factor-related apoptosis-inducing ligand on apoptosis of human colon cancer cell line RKO cells
下载PDF
导出
摘要 目的:探讨γ-干扰素(IFN-γ)对肿瘤坏死因子相关凋亡诱导配体(TRAIL)抑制人大肠癌细胞株作用的影响。方法:以大肠癌细胞株RKO为对象,采用MTT比色法和流式细胞术研究IFN-γ对TRAIL抑制RKO的影响。结果:IFN-γ组、TRAIL组和IFN-γ72h+TRAIL组的存活分数分别为99·28%、85·45%、52·60%。IFN-γ组、TRAIL组、IFN-γ24h+TRAIL组、IFN-γ48h+TRAIL组和IFN-γ72h+TRAIL组的凋亡率分别为1·51%、2·38%、4·97%、13·30%、21·00%。IFN-γ24h+TRAIL组的凋亡率高于IFN-γ组与TRAIL组的凋亡率之和(P<0·01)。随着IFN-γ预处理时间的延长,TRAIL引起RKO的凋亡率也明显上升(P<0·01)。结论:IFN-γ能有效加强TRAIL对RKO细胞株的凋亡诱导作用。 AIM: To explore the influence of IFN - γ on the role of tumor necrosis factor - related apoptosis - inducing ligand (TRAIL) in inducing apoptosis of RKO cell line. METHODS: Survival fraction and apoptosis were measured by MTI' method and flow cytometry ( FACS). RESULTS: Survival fraction of IFN - γ group, TRAIL and IFN - γ 72 h + TRAIL group were 99.28%, 85.45%, 52.60%, respectively. The percentage of apoptotic cells of IFN - γ group, TRAIL group, IFN - γ 24 h + TRAIL group, IFN - γ 48 h + TRAIL and IFN - γ 72 h + TRAIL group were 1.51%, 2.38%, 4.97%, 13.30%, 21.00%, re- spectively. The percentage of apoptotic cells of IFN - γ 24 h + TRAIL group was higher than the sum of IFN - γ group and TRAIL group ( P 〈 0.01 ). The longer the IFN - γ pretreated, the higher the percentage of apoptotic cells was observed ( P 〈 0.01 ). CONCLUSION : IFN - γ can reinforce the effect of TRAIL inducing apoptosis in RKO.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2006年第2期365-367,共3页 Chinese Journal of Pathophysiology
基金 浙江省自然科学基金资助项目(No.302678)
关键词 干扰素Ⅱ型 RKO细胞株 肿瘤坏死因子相关凋亡诱导配体 Interferon type Ⅱ RKO cell line Tumor necrosis factor- related apoptosis- inducing ligand
  • 相关文献

参考文献5

  • 1Eggert A,Grotzer MA,Zuzak TJ,et al.Resistance to tumor necrosis factor- related apoptosis- inducing ligand(TRAIL)-induced apoptosis in neurobastoma cells correlates with a loss of caspase- 8 expression[J].Cancer Res,2001,61(4):1314- 1319. 被引量:1
  • 2Yeh YA,Herenyiova M,Weber G.Quercetin:synergistic action with carboxyamido - triaxole in human breast carcinoma cells[J].Life Sci,1995,57(13):1285- 1292. 被引量:1
  • 3Kakimi K,Guidotti LG,Koezuka Y,et al.Natural killer T cell activation inhibits hepatitis B virus replication in vivo[J].J Exp Med,2000,192(7):921 - 930. 被引量:1
  • 4Shin EC,Ahn JM,Kim CH,et al.IFN- γ induces cell death in human hepatoma cells through a TRAIL/Death receptor- mediated apoptotic pathway[J].Int J Cancer,2001,93(2):262 - 268. 被引量:1
  • 5Xuezhong Yang,Melinda S,Merchant,et al.Induction of caspase 8 by interferon gamma renders some neuroblastoma(NB) cells sensitive to tumor necrosis factor- related apoptosis- inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB[J].Cancer Res,2003,63(5):1122 - 1129. 被引量:1

同被引文献23

  • 1王琪影,牛扶幼,翟晓梅.小儿血管瘤组织TRAIL蛋白与细胞增殖和凋亡检测[J].郑州大学学报(医学版),2007,42(3):548-550. 被引量:3
  • 2Nusslein-Volhard C,Wieschaus E.Mutations affecting segment number and polarity in Drosophila[J].Nature,1980,287(5785):795-801. 被引量:1
  • 3Crompton T,Outram SV,Hager-Theodorides AL.Sonic hedgehog signalling in T-cell development and activation[J].Nat Rev Immunol,2007,7(9):726-735. 被引量:1
  • 4Nagase T,Nagase M,Machida M,et al.Hedgehog signaling:a biophysical or biomechanical modulator in embryonic development?[J].Ann N Y Acad Sci,2007,1101:412-438. 被引量:1
  • 5Wetmore C.Sonic hedgehog in normal and neoplastic proliferation:insight gained from human tumors and animal models[J].Curr Opin Genet Dev,2003,13(1):34-42. 被引量:1
  • 6Rowbotham NJ,Hager-Theodorides AL,Cebecauer M,et al.Activation of the Hedgehog signaling pathway in T-lineage cells inhibits TCR repertoire selection in the thymus and peripheral T-cell activation[J].Blood,2007,109(9):3757-3766. 被引量:1
  • 7Chaudary N,Pintilie M,Hedley D,et al.Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation[J].Cancer,2011.[Epub ahead of print]. 被引量:1
  • 8Sasai K,Romer JT,Lee Y,et al.Shh pathway activity is down-regulated in cultured medulloblastoma cells:implications for preclinical studies[J].Cancer Res,2006,66(8):4215-4222. 被引量:1
  • 9Dunn GP,Bruce AT,Ikeda H,et al.Cancer immunoediting:from immunosurveillance to tumor escape[J].Nature Immunol,2002,3 (11):991-998. 被引量:1
  • 10Subleski JJ,Wiltrout RH,Weiss JM.Application of tissue-specific NK and NKT cell activity for tumor immunotherapy[J].J Autoimmun,2009,33(3-4):275-281. 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部